Live Breaking News & Updates on Type 2 inflammation

Stay informed with the latest breaking news from Type 2 inflammation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Type 2 inflammation and stay connected to the pulse of your community

Data From Phase 3 Trials Demonstrate Efficacy of Dupilumab for Treating COPD, Type 2 Inflammation

Patients with uncontrolled chronic obstructive pulmonary disease (COPD) and type 2 inflammation had significantly better lung function at least a year into a dupilumab regimen.



Ivelin-radkov , Naimish-patel , Georged-yancopoulos , European-medicines-agency , Global-development , Copd- , Phase-3-trials , Dupilumab , Type-2-inflammation ,

Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPD

Surya Bhatt, MD, associate professor of medicine at University of Alabama at Birmingham, talks about a new trial in which dupilumab was used in patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations and type 2 inflammation.

United-states , American , Surya-bhatt , American-thoracic-society , International-conference , University-of-alabama-at-birmingham , Eosinophil-counts , Ats , Copd , Dupilumab , Exacerbations , Type-2-inflammation

Treatment Improves Outcomes in Patients With CRSwNP, Features of Obstructive Lung Disease

In the phase 3 SINUS-24 and SINUS-52 trials, dupilumab improved clinical outcomes and and health-related quality of life among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and clinical features of obstructive lung disease.

University-of-pennsylvania-smell-identification-test , Pennsylvania-smell-identification-test , Sino-nasal-outcome-test , Sinus-24 , Sinus-52 , Crswnp , Dupilumab , Obstructive-lung-disease , Type-2-inflammation , Copd ,